Intestinal permeability and cirrhosis;Perméabilité intestinale et cirrhose

Gastroenterologie Clinique et Biologique

Volumn 30, Issue 3, 2006, Pages 460-468

  Ancel, David ^a   Barraud, Hélène ^a   Peyrin Biroulet, Laurent ^a   Bronowicki, Jean Pierre ^a,b  

^a CHU NANCY BRABOIS   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIINFECTIVE AGENT;

ALCOHOL LIVER CIRRHOSIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ASCITES FLUID ANALYSIS; BACTERIAL PERITONITIS; HUMAN; HYPERBILIRUBINEMIA; INFECTION RISK; INTESTINE FUNCTION; INTESTINE MUCOSA PERMEABILITY; LABORATORY TEST; LIVER CIRRHOSIS; PORTAL HYPERTENSION; REVIEW; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA;

EID: 33745772598     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-8320(06)73203-1     Document Type: Article

References (74)

1. Garcia-Tsao G. Current managment of the complications of cirrhosis and portal hypertension: variceal hemmorrhage, ascites and spontaneous bacterial peritonitis. Gastroenterology 2001;120:726-48.
2. Rimola A, Garcia-Tsao G, Navasa M, Piddock L, Planas R, Bernard B, et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. J Hepatol 2000;32:142-53.
3. Deschenes M, Villeneuve JP. Risk factors for the development of bacterial infections in hospitalised patients with cirrhosis. Am J Gastroenterol 1999;94:2193-7.
4. Runyon B, Squier S, Borzio M. Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis. J Hepatol 1994;21:792-6.
5. Rosa H, Silverio A, Perini R, Arruda C. Bacterial infection in cirrhotic patients and its relationship with alcohol. Am J Gastroenterol 2000;95:1290-93.
6. Travis S, Menzies I. Intestinal permeability: functionnal assessment and significance. Clin.Sci. 1992;82:471-88.
7. Kagnoff M. Immunology and inflammation of the gastrointestinal tract. In: Feldman M, Scharschmidt BF, Sleisenger MH, eds. Sleisenger and Fordtran's gastro intestinal and liver disease, 6th ed. Philadelphia: WB Saunders. 1998:19-48.
8. Brandtzaeg P, Halstensen TS, Kett K, Krajci P, Kvale D, Rognum TO, et al. Immunology and immunopathology of human gut mucosa : humoral immunity and intraepithelial lymphocytes. Gastroenterology 1989;97:1562-84.
9. Guy-Grand D, Disanto JP, Henchoz P, Malassis-Seris M, Vassalli P. Small bowel enteropathy. Role of intraepithelial lymphocytes and cytokines (IL-12, IFN-Gamma, TNF) in the induction of epithelial cell death and renewal. Eur J Immunol 1998;28:730-44.
10. Thomas Y, Nguyen D, Bui V, Nguyen H, Hoa N. Ethanol modulation of intestinal epithelial tight junction barrier. Am. J. Physiol 1999;276:965-74.
11. Baraona E, Pirola R, Lieber C. Small intestinal damage and changes in cell population produced by ethanol ingestion in the rat. Gatsroenterology 1974;66:226-34.
12. Rubin E, Rybak B, Lindenbaum J, Gerson C, Walker G, Lieber C. Ultrastructural changes in the small intestine induced by ethanol. Gastroenterology 1972;63:801-14.
13. Beck IT, Dinda PK. Acute exposure of small intestine to ethanol: effects on morphology and function. Dig.Dis.Sci 1981;26:817-38.
14. Persson J, Berg NO, Sjownok J, Stenling G R, Magnusson P. Morphologic changes in the small intestine after chronic alcohol consumption. Scand.J.Gastroenterol 1990;25:173-84.
15. Eugene J, Burbige D, Lewis R, Halsted C. Alcohol and the gastrointestinal tract. Med Clin North Am 1984;68:77-89.
16. Such J, Guardiola JV, De Juan J, Casellas J, Pascual S, Aparicio J, et al. Ultrastructural characteristics of distal duodenum mucosa in patients with cirrhosis. Eur J Gastroenterol Hepatol 2002;14:371-76.
17. Aastaldi G, Strosselli E. Peroral biopsy of the intestinal mucosa in hepatic cirrhosis. Am J Dig Dis 1960;5:603-12.
18. Schachter D. Fluidity and function of hepatocyte plasma membranes. Hepatology 1984;4:140-51.
19. Schuller A, Moscat J, Diez E, Fernandez-Checa C, Gavilantes F, Municio A. The fluidity of plasma membranes from ethanol-treated rat liver. Mol Cell Biochem 1984;64:89-95.
20. Baraona E, Pirola R, Lieber C. Acute and chronic effects of ethanol on intestinal. Biochim Biophys Acta 1975;388:19-28.
21. Rubin E, Rottenberg H. Ethanol-induced injury and adaptation in biological membranes. Alcohol Dis 1982;41:2465-71.
22. Lindi C, Marciani P, Montofarno G, Omodeo-Sale F. Age-related effects of chronic ethanol intake on physical properties, lipid composition and galactosyltransferase activity of rat small intestine micosomes. Alcohol Alcohol 1996;31:183-9.
23. Schuller A, Solis-Herruzo J, Moscat J, Fernandez-Checa J, Municio A. The fluidity of liver plasma membranes from patients with different types of liver injury. Hepatology 1986;6:714-7.
24. Mc Cormack T, Sims J, Eyre-Brook E. Gastric lesions in portal hypertension: inflammatory gastritis or congestive gastropathy? Gut 1985;26:1126-32.
25. Tarnawski A, Sarfeh I, Stachura J, Hajduczek A, Bui H, Dabros W. Microvascular abnormalities of the portal hypertensive gastric mucosa. Hepatology 1988;8:1488-94.
26. Nagral A, Joshi A, Bhatia S, AbrahamP, Mistry F, Vora I. Congestive jejunopathy in portal hypertension.Gut 1993;34:694-7.
27. Misra V, Misra S, Dwivedi M, Gupta S. Histomorphometric study of portal hypertension enteropathy. Am J Clin Pathol 1997;108:652-7.
28. Hashimoto N, Ohyanagi H. Effect of acute portal hypertension on gut mucosa. Hepatogastroenterology 2002;49:1567-70.
29. Bode J, Bode C, Heidebatch R, Durr H, Martini G. Jejunal microflora in patients with chronic alcohol abuse. Hepatogastroenterology 1984;31:30-4.
30. Bauer T, Steinbrückner B, Brinkmann F, Ditzen A, Schawacha H, Aponte J. Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis. Am J Gastroenterol 2001;96:2962-7.
31. Bauer T, Schwacha H, Steinbrucker B, Brinkmann F, Ditzen A, Aponte J. Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxinemia. Am J Gastroenterol 1998;33:867-71.
32. Chesta J, Defilippi C. Abnormalities in proximal small bowell motility in patients with cirrhosis. Hepatology 1993;17:828-32.
33. Shindo K, Machida M, Miyakawa K, Fukumura M. A syndrome of cirrhosis, achlorhydria, small intestinal bacterial overgrowth and fat malabortion. Am J Gastroenterol 1993;88:2084-91.
34. Deitch E, Sittig K, Li M, Berg R, Specian R. Obstructive jaundice promots bacterial translocation from the gut. Am J Surg 1990;159:79-84.
35. Perez- Paramo M, Munoz J, Albillos A, Freile I, Portero F, Santos M. Effect of propanolol on the factors promoting bacterial translocation in cirrhotic rats with ascites. Hepatology 2000;31:43-8.
36. Campillo B, Pernet P, Bories P, Richardet JP, Devanlay M, Aussel C. Intestinal permeability in liver cirrhosis: relationship with severe septic complications. Eur J Gastroenterol 1999;11:755-9.
37. Gascia-Tsao G. Bacterial translocation: cause or consequence of decompensation in cirrhosis? J Hepatol 2001;34:150-5.
38. Guarner C, Soriano G, Thomas A, Bulbena O, Novella M, Balanzo J. Increased serum nitrate and nitrate levels in patients with cirrhosis. Relationship to endotoxemia. Hepatology 1993;18:1139-43.
39. Jouet P, Grange J-D. Flore bactérienne et cirrhose. Gastroenterol Clin Biol 2003;27:738-48.
40. Grozman RJ. Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences. Hepathology 1994;20:1359-63.
41. Banan A, Fields J, Decker H, Zhang Y, Kesharazian A. Nitric oxide and its metabolites mediate ethanol-induced microtubule disruption and intestinal barrier dysfunction. J Pharmacol Exp Therap 2000;204:997-1007.
42. Poritz LS, Garver KI, Tilberg AF, Koltun WA. Tumor necrosis factor alpha disrupts tight junction assembly. J Surg Res 2004;116:14-8.
43. Chu CJ, Lee FY, Wang ss lu RH, Tsai YT, Lin HC. Hyperdynamic circulation in cirrhotic rats with ascites: role of endotoxin, tumour necrosis factor-alpha and nitric oxide. Clin Sci 1997;93:219-25.
44. Ramachandran A, Prabhu R, Thomas S, Reddy J, Pulimood A, Balasubramanian K. Intestinal mucosal alterations in experimental cirrhosis in the rat: role of free oxygen free radicals. Hepatology 2002;32:622-8.
45. Menzies I.S. Absorption of intact oligosaccharide in health and disease. Biochem Soc Trans 1974;2:1042-6.
46. 51Cr-labelled ethylenediaminetetra-acetate as markers of intestinal permeability in man. Clin Sci 1987;73:197-204.
47. 51Cr-labelled ethylenediaminetetra-acetate, L-rhamnose and polyethyleneglycol 500 as probe markers for assessment in vivo of human intestinal permeability. Clin Sci 1986;71:71-80.
48. Bjarnasson I, Macpherson A, Hollander D. Intestinal permeability: an overview. Gastroenterology 1995;108:1566-81.
49. Ukabam S, Cooper B. Small intestinal permeability to mannitol, lactulose, and polyethylene glycol 400 in celiac disease. Dig Dis Sci 1984;29:809-16.
50. Bjarnasson I. Intestinal permeability. Gut 1994;35(suppl 1):S 18-22.
51. Thomas Y, Hollander D, Krugliak P, Katz K. PEG 400, a hydrophobic molecular probe for measuring intestinal permeability. Gastroenterology 1990;98:39-46.
52. Intestinal Permeability (Editorial). Lancet 1985;1:256-7.
53. Harding SE, Ukabam SO. Mathematical models of determining intestinal permeability using polyethylene glycol. Gut 1982;21:208-14.
54. Peters TJ, Bjarnasson I. Uses and abuses of intestinal permeability measurments. Can J Gastroenterol 1988;2:127-32.
55. Bjarnasson I, Maxton D, Reynolds A, Petrers T, Levi A, Menzies IS. Comparison of 4 different markers of intestinal permeability (abstract). Gastroenterology 1985;88:1326.
56. ..PA. Dig Dis Sci 1990;35:205-11.
57. Bac D, Swart G, Willem J, Van Der Berg O, Paul Wilson J. Small bowel wall function in patients with advanced liver and portal hypertension: studies on permeability and luminal bacterial overgrowth. Eur J Gastroenterol Hepatol 1993;5:383-7.
58. Ersoz G, Aydin A, Eerdem S, Yuksel D, Akarca U, Kumanlioglu K, et al. Intestinal permeability in liver cirrhosis. Eur J Gastroenterol 2000;95:1290-93.
59. Fuchs M, Pfeiffer A, Kuntzen O, Kaess H. Intestinal permeability in liver cirrhosis (abstract). Gatsroenterology 1997;112(suppl.4):A1266.
60. Zuckerman, Menzies IS, Ho H, Hernandez J, Casner N, Masih R, et al. Assessment of intestinal permeability using sugar solutions in cirrhotic patients with ascites (abstract). Gastroenterology 1996;A1369.
61. Fujii T, Seki T, Maruoka M, Tanaka J, Kawashima Y, Watanabe T, et al. Lactulose-L-rhamnose intestinal permeability test in patients with liver cirrhosis. Hepatol Res 2001;19:158-69.
62. Budillon G, Parilli G, Pacella M, Cuomo R, Menzies IS. Investigation of intestine and liver function in cirrhosis using combined sugar oral loads. J Hepatol 1985;1:513-24.
63. Piquet M, Laurent D, Manceau S, Even C, Collet T, Arsene D, et al. Increased intestinal permeability in patients with cirrhosis (abstract). Gastroenterology 1997;112:A1 266.
64. Pascual S, Such J, Esteban A, Zapater P, Casellas JA, Aparicio JR, et al. Intestinal permeability is increased in patients with advanced cirrhosis. Hepatogastroenterology 2003;50:1482-6.
65. Di Leo V, Venturi C, Baragiotta A, Martines D, Floreani A. Gastroduodenal and intestinal permeability in primary biliary cirrhosis. Eur J Gastroenterol Hepatol 2003,15:967-73.
66. Bijlsma P, Peeters R, Groot J, Kekker P, Taminiau M, Van Der Meer R. Differential in vivo and in vitro intestinal permeability to lactulose and mannitol in animals and humans: a hypothesis. Gastroenterology 1995;108:687-96.
67. Wirth HP, Meyenberger C, Ammann R, Blum HE. Parietal cells antibodies in primary biliary cirrhosis: pathogenetic or diagnostic significance? Schweiz Med Wochenschr 1994;124:816-20.
68. Buts JP, De Keysez N, Collette E, Bonsignore M, Lambotte L, Desjeux JF. Intestinal transport of calcium in rat biliary cirrhosis. Pediatr Res 1996;40:533-41.
69. Barnard JA, Beauchamp RD, Russel WE, Dubois RN, Coffey RJ. Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology. Gastroenterology 1995;108:564-80.
70. Floreani A, Baragiotta A, Pizzuti D, Martines D, Cecchetto A, Chiarelli S. Mucosal IgA defect in primary biliary cirrhosis. Am J Gastroenterol 2002;97:508-10.
71. Sarin SK, Dhingra N, Bansal A. Dietary and nutrition abnormalities in alcoholic liver disease: a comparison with chronic alcoholics without liver disease. Am J Gastroenterol 1997;92: 777-83.
72. Rosa H, Silverio A, Perini R, Arruda C. Bacterial infection in cirrhotic patients and its relationship with alcohol. Am J Gastroenterol 2000;95:1290-3.
73. Grangé J-D. Comment traiter une ascile ? Gastroenterol Clin Biol 2004;28:B278-86.
74. Guarner C, Sola R, Soriano G, Andrieu M, Novella MT, Vila MC. Risk of a first community-acquired spontaneous bacterial peritonitis in cirrhosis with low ascetic fluid protein levels. Gastroenterology 1999;117:414-9.